Earnings : What to expect NASDAQ:MIST, NASDAQ:SPPI, NASDAQ:WBA, NASDAQ:RMTI

Milestone Pharmaceuticals Stock Forecast, Price & News (NASDAQ:MIST)

Milestone Pharmaceuticals last posted its earnings results on March 28th, 2021. The reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.28. Milestone Pharmaceuticals has generated ($3.50) earnings per share over the last year. Milestone Pharmaceuticals has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, May 13th, 2021 based off prior year’s report dates.

IS MILESTONE PHARMACEUTICALS A BUY RIGHT NOW? (NASDAQ:MIST)

5 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Milestone Pharmaceuticals in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Milestone Pharmaceuticals stock.
Milestone Pharmaceuticals

SPECTRUM PHARMACEUTICALS (NASDAQ:SPPI) EARNINGS INFORMATION (NASDAQ:SPPI)

Spectrum Pharmaceuticals last posted its quarterly earnings results on March 29th, 2021. The biotechnology company reported ($0.29) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.29). Spectrum Pharmaceuticals has generated ($1.14) earnings per share over the last year. Spectrum Pharmaceuticals has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, May 6th, 2021 based off prior year’s report dates.

IS SPECTRUM PHARMACEUTICALS A BUY RIGHT NOW? (NASDAQ:SPPI)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Spectrum Pharmaceuticals in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Spectrum Pharmaceuticals stock.
Spectrum Pharmaceuticals

WALGREENS BOOTS ALLIANCE (NASDAQ:WBA) EARNINGS INFORMATION (NASDAQ:WBA)

Walgreens Boots Alliance last released its quarterly earnings results on March 30th, 2021. The pharmacy operator reported $1.40 EPS for the quarter, topping the consensus estimate of $1.10 by $0.30. The business earned $32.78 billion during the quarter, compared to analysts’ expectations of $36.16 billion. Its revenue was down 8.5% on a year-over-year basis. Walgreens Boots Alliance has generated $4.74 earnings per share over the last year and currently has a price-to-earnings ratio of 109.5. Walgreens Boots Alliance has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, July 8th, 2021 based off prior year’s report dates.

IS WALGREENS BOOTS ALLIANCE A BUY RIGHT NOW? (NASDAQ:WBA)

16 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Walgreens Boots Alliance in the last twelve months. There are currently 2 sell ratings, 12 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Walgreens Boots Alliance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
Walgreens Boots Alliance

ROCKWELL MEDICAL (NASDAQ:RMTI) EARNINGS INFORMATION (NASDAQ:RMTI)

Rockwell Medical last posted its quarterly earnings results on March 30th, 2021. The reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.01. Rockwell Medical has generated ($0.56) earnings per share over the last year. Rockwell Medical has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, May 10th, 2021 based off prior year’s report dates.

IS ROCKWELL MEDICAL A BUY RIGHT NOW? (NASDAQ:RMTI)

1 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Rockwell Medical stock.
Rockwell Medical